TARA Protara Therapeutics, Inc.

8-K Current Report

Filed: March 10, 2026

Health Care

Biological Products, (No Diagnostic Substances)

Protara Therapeutics, Inc. (TARA) 8-K current report filed with SEC EDGAR on March 10, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Protara Therapeutics (TARA) filed earnings results via Exhibit 99.1 press release — full financials contained in that exhibit
• Furnished (not "filed") under SEC rules, meaning no Section 18 liability — standard practice for earnings releases

+1 more insights

Other Protara Therapeutics, Inc. 8-K Filings

8-K Feb 24, 2026

Get deeper insights on Protara Therapeutics, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.